Evidence map›Paper›PMID 41542467›Full record

ArticlebioRxiv : the preprint server for biology2026

Targeted Lipid Metabolism Screening Uncovers Regulatory Effects on the STING Immune Response in Mevalonate, Eicosanoid and Fatty Acid Pathways.

Sofia Skobelkina, Ella L Brunsting, Darren J Perkins

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sofia SkobelkinaProgram in Oncology Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, 685 W. Baltimore St., Suite 380, Baltimore, MD 21201.
Ella L BrunstingDepartment of Microbiology and Immunology University of Maryland, Baltimore (UMB), School of Medicine.ORCID 0000-0001-7758-898X
Darren J PerkinsProgram in Oncology Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, 685 W. Baltimore St., Suite 380, Baltimore, MD 21201.ORCID 0000-0003-1368-6366

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defenseR21AI180181 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PERKINS, DARREN · 2024 to 2025
$428k
PGE2 Receptor Suppression of cGAS/STING Responses in anti-tumor immunityR21AI152051 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PERKINS, DARREN · 2020 to 2021
$425k
NIAID NIH HHS R21 AI152051NIAID NIH HHS R21 AI180181NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

The cGAS/STING pathway is a critical signaling hub that orchestrates type I interferon (IFN) responses, autophagy, and programmed cell death in response to double-stranded DNA (dsDNA) or cyclic dinucleotides. While traditionally characterized as a sensor of foreign or mis-localized self dsDNA, recent evidence demonstrates that STING also integrates information about the homeostasis of cellular lipid biosynthesis into the innate inflammatory response. This integration occurs most notably through STING's sensitivity to

Indexed as

5-LipoxygenasecholesterollipidPPAR gammaSTING

Identifiers

PMID41542467
PMCPMC12803197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.